Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 May;31(5):1171-1178.
doi: 10.1007/s43032-023-01418-2. Epub 2023 Dec 18.

Recurrence of Uterine Fibroids After Conservative Surgery or Radiological Procedures: a Narrative Review

Affiliations
Review

Recurrence of Uterine Fibroids After Conservative Surgery or Radiological Procedures: a Narrative Review

Tommaso Capezzuoli et al. Reprod Sci. 2024 May.

Abstract

The present narrative review aims to discuss the available data on the incidence and the risk factors of uterine fibroids (UFs) recurrence after different types of conservative surgical or radiologic procedures in women wishing to preserve their uterus. UFs are the most common benign tumors in women all over the world. Clinical presentation, including abnormal uterine bleeding (AUB), pelvic pain, bulky symptoms, and infertility affect patients' quality of life, and a large variety of conservative treatments are available especially for those with desire of pregnancy. Fertility sparing surgery, by either laparoscopy, hysteroscopy or laparotomy, or radiological interventions (uterine artery embolization, high-intensity focused ultrasound or magnetic resonance-guided focused ultrasound), are the most common therapeutic approaches. However, the genetic or acquired predisposition to UFs remain despite the treatments, and the recurrences are frequently described in a large percentage of patients. The most relevant risk factors for recurrence of UFs are young age at the first surgery, incomplete fibroid resection, the presence of multiple lesions, an enlarged uterus, and the coexistence with other pelvic diseases. The discussion on the possible medical strategy to reduce the recurrence is an open field of clinical investigation, in particular by using hormonal drugs.

Keywords: Interventional radiology procedures; Medical treatment; Recurrence; Surgery; Uterine fibroids.

PubMed Disclaimer

Similar articles

  • The management of uterine leiomyomas.
    Vilos GA, Allaire C, Laberge PY, Leyland N; SPECIAL CONTRIBUTORS. Vilos GA, et al. J Obstet Gynaecol Can. 2015 Feb;37(2):157-178. doi: 10.1016/S1701-2163(15)30338-8. J Obstet Gynaecol Can. 2015. PMID: 25767949
  • The management of uterine leiomyomas.
    Lefebvre G, Vilos G, Allaire C, Jeffrey J, Arneja J, Birch C, Fortier M, Wagner MS; Clinical Practice Gynaecology Committee, Society for Obstetricians and Gynaecologists of Canada. Lefebvre G, et al. J Obstet Gynaecol Can. 2003 May;25(5):396-418; quiz 419-22. J Obstet Gynaecol Can. 2003. PMID: 12738981
  • The modern management of uterine fibroids-related abnormal uterine bleeding.
    Vannuccini S, Petraglia F, Carmona F, Calaf J, Chapron C. Vannuccini S, et al. Fertil Steril. 2024 Jul;122(1):20-30. doi: 10.1016/j.fertnstert.2024.04.041. Epub 2024 May 8. Fertil Steril. 2024. PMID: 38723935 Review.
  • The management of uterine fibroids in women with otherwise unexplained infertility.
    Carranza-Mamane B, Havelock J, Hemmings R; REPRODUCTIVE ENDOCRINOLOGY AND INFERTILITY COMMITTEE; SPECIAL CONTRIBUTOR. Carranza-Mamane B, et al. J Obstet Gynaecol Can. 2015 Mar;37(3):277-285. doi: 10.1016/S1701-2163(15)30318-2. J Obstet Gynaecol Can. 2015. PMID: 26001875
  • Currently Available Treatment Modalities for Uterine Fibroids.
    Micić J, Macura M, Andjić M, Ivanović K, Dotlić J, Micić DD, Arsenijević V, Stojnić J, Bila J, Babić S, Šljivančanin U, Stanišić DM, Dokić M. Micić J, et al. Medicina (Kaunas). 2024 May 26;60(6):868. doi: 10.3390/medicina60060868. Medicina (Kaunas). 2024. PMID: 38929485 Free PMC article. Review.

References

    1. Pavone D, Clemenza S, Sorbi F, Fambrini M, Petraglia F. Epidemiology and risk factors of uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2018;46:3–11. - PubMed
    1. Stewart EA, Adelman MR, Jacoby VL. ACOG PRACTICE BULLETIN clinical management guidelines for obstetrician-gynecologists NUMBER 228. 2021.
    1. Yang Q, Ciebiera M, Bariani MV, Ali M, Elkafas H, Boyer TG, et al. Comprehensive review of uterine fibroids: developmental origin, pathogenesis, and treatment. Endocr Rev. 2022;43(4):678–719. - PubMed
    1. Soliman AM, Margolis MK, Castelli-Haley J, Fuldeore MJ, Owens CD, Coyne KS. Impact of uterine fibroid symptoms on health-related quality of life of US women: evidence from a cross-sectional survey. Curr Med Res Opin. 2017;33(11):1971–8. - PubMed
    1. Fortin C, Flyckt R, Falcone T. Alternatives to hysterectomy: the burden of fibroids and the quality of life. Best Pract Res Clin Obstet Gynaecol. 2018;46:31–42. - PubMed

LinkOut - more resources